tirzepatide 2.5 mg/0.5 ml subcutaneous pen injector Zepbound Injection — Mountainside Medical Tirzepatide (Mounjaro) In Sherman Oaks

We explain all the important information.

Your practitioner will assess your treatment on a regular basis

Tirzepatide displayed an unprecedented glucose and body weight lowering potential, presenting also with the ability to increase insulin sensitivity, reduce systolic blood pressure and inflammation and ameliorate dyslipidemia, particularly by reducing triglycerides levels

Mounjaro is an FDA-approved, dual-targeted weight loss injection that decreases food intake, regulates energy expenditure, and significantly impacts metabolic dysregulation.

Tirzepatide is not approved or recommended for treating ADHD (Attention-Deficit/Hyperactivity Disorder)

Learn how GLP-1 therapy supports weight loss and wellness in Arlington & Northern VA